The earnings call highlighted Evogene's strategic efforts to reduce expenses and successfully execute acquisitions, leading to a more sustainable financial position. However, it also revealed a significant revenue decline and the need for additional funding for certain projects, balancing out the positive achievements.

Company Guidance -

Q2 2025

During the first quarter of 2025, Evogene reported total revenues of approximately $2.4 million, a decrease from $4.2 million in the same period in 2024. This decline was primarily due to the previous year's inclusion of significant license fee payments. The primary revenue driver in 2025 was an increase in seed sales by Casterra. The company implemented an expense reduction plan, reflected in reduced operating expenses of approximately $5 million compared to $8 million in 2024. R&D expenses were reduced to $3.2 million from $4.8 million, and sales and marketing expenses decreased to $645,000 from $1 million. As of the end of the first quarter, cash and short-term bank deposits were approximately $9.8 million. Evogene also highlighted a transaction with ICL, expected to close in the second quarter, involving the acquisition of Lavie Bio's assets, valued at $15.25 million, and the MicroBoost AI for Ag tech-engine for $3.5 million.

Expense Reduction Plan

Evogene has established an expense reduction plan reflected in the first-quarter results and expects it to be completed by the second quarter of 2025. This plan led to a decrease in total operating expenses from $8 million in Q1 2024 to $5 million in Q1 2025.

Successful Acquisition of Lavie Bio by ICL

Evogene announced the acquisition of Lavie Bio's activities by ICL for $15.25 million, plus $3.5 million for the MicroBoost AI tech-engine. The deal is expected to close in the second quarter of 2025.

Casterra's Seed Sales Growth

Casterra delivered 250 tons of castor seeds in Q1 2025, surpassing the 215 tons delivered in the entire year of 2024, indicating strong growth in this segment.

AgPlenus' New Fungicide Discovery

AgPlenus discovered a new mode of action for fungicides against Septoria in wheat, with plans to engage licensing partners by year-end.

Advancements in ChemPass-AI for Pharma

Evogene has made substantial progress in refining ChemPass-AI for pharma, particularly in its collaboration with Google Cloud to develop a foundation model application.

Evogene (EVGN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

EVGN Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 19, 2025	2025 (Q2)	-0.63 / -	-1.06	―	―	―
May 21, 2025	2025 (Q1)	-0.51 / -0.38	-0.8	52.50% (+0.42)	―
Mar 06, 2025	2024 (Q4)	-0.72 / 0.06	-1.3	104.62% (+1.36)
Nov 21, 2024	2024 (Q3)	-1.01 / -1.31	-0.8	-63.75% (-0.51)	―
Aug 22, 2024	2024 (Q2)	-1.25 / -1.06	-1.7	37.65% (+0.64)	―
May 23, 2024	2024 (Q1)	-0.95 / -0.80	-1.5	46.67% (+0.70)	―
Mar 07, 2024	2023 (Q4)	-1.40 / -1.30	-0.7	-85.71% (-0.60)	―
Nov 15, 2023	2023 (Q3)	-1.57 / -0.80	-1.6	50.00% (+0.80)	―	―
Aug 17, 2023	2023 (Q2)	-1.75 / -1.70	-2.1	19.05% (+0.40)	―	―
May 18, 2023	2023 (Q1)	-1.60 / -1.50	-2	25.00% (+0.50)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

EVGN Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 21, 2025	$1.27	$1.18	-7.09%
Mar 06, 2025	$1.41	$1.41	0.00%
Nov 21, 2024	$1.65	$1.60	-3.03%
Aug 22, 2024	$3.98	$3.55	-10.80%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Evogene Ltd. (EVGN) report earnings?

Evogene Ltd. (EVGN) is schdueled to report earning on Aug 19, 2025, TBA (Confirmed).

What is Evogene Ltd. (EVGN) earnings time?

Evogene Ltd. (EVGN) earnings time is at Aug 19, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is EVGN EPS forecast?

EVGN EPS forecast for the fiscal quarter 2025 (Q2) is -0.63.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing